Healthcare entity
Every one of those 1 sits in a single category, regulation. Stephen Wiley is most often covered alongside Andrew Berens, which appears in 1 of these 1 story. Stephen Wiley appears in 1 tracked Healthcare story from July 20, 2026.
Last mentioned: Jul 20, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, regulation. Stephen Wiley is most often covered alongside Andrew Berens, which appears in 1 of these 1 story. Stephen Wiley appears in 1 tracked Healthcare story from July 20, 2026. The tracked stories average 1 original source each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 19 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Stephen Wiley. Shared-story counts are live from our verified record — not editorial picks.
Pomerantz LLP probes Celcuity after FDA-approved breast cancer therapy Revtorpyk sees delayed Q3 2026 commercial launch, sending shares down 17.6%. Analysts question prior launch readiness; health investors weigh biotech regulatory and execution risks.
Source: prnewswire.com
Stephen Wiley is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
